LVAC
Price:
$10.43
Market Cap:
$149.93M
LAVA Medtech Acquisition Corp. does not have significant operations. It intends to acquire assets and businesses through a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization. The company focuses on pursuing opportunities in healthcare and healthcare-related industries. The company was incorporated in 2021 and is based in Waltham, Massachusetts. LAVA Medtech Acquisition Corp. is a subsidiary of LAVA Medtech Sponsor LP.[Read more]
Industry
Shell Companies
IPO Date
2021-12-17
Stock Exchange
NASDAQ
Ticker
LVAC
According to LAVA Medtech Acquisition Corp.’s latest financial reports and current stock price. The company's current ROE is 3.96%. This represents a change of 302.26% compared to the average of 0.99% of the last 4 quarters.
The mean historical ROE of LAVA Medtech Acquisition Corp. over the last ten years is 10.01%. The current 3.96% ROE has changed -60.40% with respect to the historical average. Over the past ten years (40 quarters), LVAC's ROE was at its highest in in the June 2022 quarter at 1.53%. The ROE was at its lowest in in the December 2021 quarter at -277724.00%.
Average
10.01%
Median
10.01%
Minimum
3.89%
Maximum
16.13%
Discovering the peaks and valleys of LAVA Medtech Acquisition Corp. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual ROE = 16.13%
Minimum Annual Increase = -75.91%
Minimum Annual ROE = 3.89%
Year | ROE | Change |
---|---|---|
2022 | 3.89% | -75.91% |
The current ROE of LAVA Medtech Acquisition Corp. (LVAC) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
10.01%
5-year avg
10.01%
10-year avg
10.01%
LAVA Medtech Acquisition Corp.’s ROE is less than Chavant Capital Acquisition Corp. (0%), less than Swiftmerge Acquisition Corp. (12.95%), greater than Viscogliosi Brothers Acquisition Corp. (-0.42%), greater than Nubia Brand International Corp. (-1.35%), less than CF Acquisition Corp. VII (1.57%), greater than null (-3.78%),
Company | ROE | Market cap |
---|---|---|
0% | $27.52M | |
12.95% | $75.79M | |
-0.42% | $0 | |
-1.35% | $32.30M | |
1.57% | $112.98M | |
-3.78% | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like LAVA Medtech Acquisition Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like LAVA Medtech Acquisition Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is LAVA Medtech Acquisition Corp.'s ROE?
How is the ROE calculated for LAVA Medtech Acquisition Corp. (LVAC)?
What is the highest ROE for LAVA Medtech Acquisition Corp. (LVAC)?
What is the 3-year average ROE for LAVA Medtech Acquisition Corp. (LVAC)?
What is the 5-year average ROE for LAVA Medtech Acquisition Corp. (LVAC)?
How does the current ROE for LAVA Medtech Acquisition Corp. (LVAC) compare to its historical average?